Neo Citran Max C-Vitaminnal (Phenylephrine Hydrochloride, Ascorbic Acid, Paracetamol)

• Neo Citran Max C-Vitaminnal, a combination analgesic and decongestant, is used to manage the symptom complex of viral upper‑respiratory infections.
• Nasal congestion: reduces swelling of nasal mucosa and eases breathing.
• Fever: lowers elevated body temperature.
• Headache: alleviates pain associated with cold or flu.
• General cold and flu symptom relief: improves overall comfort during acute viral illness.

• Phenylephrine Hydrochloride acts as an alpha‑adrenergic agonist causing vasoconstriction of the nasal mucosa, which diminishes congestion. Paracetamol exerts analgesic and antipyretic effects through central inhibition of cyclooxygenase enzymes, reducing pain and fever. Ascorbic Acid serves as an antioxidant and vitamin C supplement, supporting normal immune function during illness.

Common Side Effects

• Nausea or stomach upset
• Dizziness or light‑headedness
• Dry mouth
• Mild headache
• Insomnia or difficulty sleeping
• Mild rash or itching

Serious or Rare Side Effects

• Allergic reactions such as swelling of the face, lips or throat
• Severe skin reactions (e.g., Stevens‑Johnson syndrome)
• Significant elevation of blood pressure
• Rapid heart rate (tachycardia)
• Liver injury or hepatitis (rare with paracetamol overdose)
• Anaphylaxis requiring emergency care

Before using Neo Citran Max C-Vitaminnal, consider the following precautions:

• Liver function: avoid in patients with severe hepatic impairment.
• Hypertension: use with caution in individuals with high blood pressure.
• Hypersensitivity: do not use if known allergy to phenylephrine, paracetamol or vitamin C.
• Concomitant products: avoid taking other medicines containing paracetamol.
• Anticoagulant therapy: monitor bleeding risk when used with warfarin or similar agents.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Neo Citran Max C-Vitaminnal may interact with several drug classes.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis with phenylephrine.
• Other paracetamol‑containing products: potential for overdose and liver toxicity.
• Anticoagulants (e.g., warfarin): increased bleeding risk due to paracetamol.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: phenylephrine may reduce their effectiveness.
• Selective serotonin reuptake inhibitors (SSRIs): possible enhanced bleeding tendency.
• Alcohol: may increase hepatic load and risk of liver injury.